Dr. Zev Zelenko, a frontline physician, speaks about the effectiveness of HCQ, and the FDA and CDC’s effort to suppress its use in favor of expensive and unproven drugs. This is mindblowing.
Dr. Harvey Risch of the Department of Infectious Disease Epidemiology at the Yale Department of Public Health speaks about hydroxychloroquine and its use in early treatment (prophylaxis) for COVID-19:
Dr. James Todaro, MD, PhD, from Columbia University speaks on hydroxychloroquine use in patients with COVID-19.
